Correlation Between CRISPR Therapeutics and Iron Mountain
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Iron Mountain at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Iron Mountain into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and Iron Mountain Incorporated, you can compare the effects of market volatilities on CRISPR Therapeutics and Iron Mountain and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Iron Mountain. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Iron Mountain.
Diversification Opportunities for CRISPR Therapeutics and Iron Mountain
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CRISPR and Iron is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Iron Mountain Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iron Mountain and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Iron Mountain. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iron Mountain has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Iron Mountain go up and down completely randomly.
Pair Corralation between CRISPR Therapeutics and Iron Mountain
Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 3.67 times more return on investment than Iron Mountain. However, CRISPR Therapeutics is 3.67 times more volatile than Iron Mountain Incorporated. It trades about -0.08 of its potential returns per unit of risk. Iron Mountain Incorporated is currently generating about -0.31 per unit of risk. If you would invest 3,152 in CRISPR Therapeutics AG on November 5, 2024 and sell it today you would lose (232.00) from holding CRISPR Therapeutics AG or give up 7.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
CRISPR Therapeutics AG vs. Iron Mountain Incorporated
Performance |
| Timeline |
| CRISPR Therapeutics |
| Iron Mountain |
CRISPR Therapeutics and Iron Mountain Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CRISPR Therapeutics and Iron Mountain
The main advantage of trading using opposite CRISPR Therapeutics and Iron Mountain positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Iron Mountain can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iron Mountain will offset losses from the drop in Iron Mountain's long position.| CRISPR Therapeutics vs. Raytheon Technologies | CRISPR Therapeutics vs. Agilent Technologies | CRISPR Therapeutics vs. Take Two Interactive Software | CRISPR Therapeutics vs. SSC Technologies Holdings, |
| Iron Mountain vs. American Tower | Iron Mountain vs. Equinix | Iron Mountain vs. Crown Castle International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |